Literature DB >> 10654001

The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787-800 (1937)

M Theiler1, H H Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10654001

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN： 1052-9276            Impact factor:   6.989


× No keyword cloud information.
  7 in total

1.  Yellow fever vaccine.

Authors:  Philip P Mortimer
Journal:  BMJ       Date:  2002-02-23

2.  Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.

Authors:  Xiaohong Jiang; Tim J Dalebout; Igor S Lukashevich; Peter J Bredenbeek; David Franco
Journal:  J Gen Virol       Date:  2014-12-16       Impact factor: 3.891

3.  E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

Review 4.  Immunity to viruses: learning from successful human vaccines.

Authors:  Bali Pulendran; Jason Z Oh; Helder I Nakaya; Rajesh Ravindran; Dmitri A Kazmin
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

5.  Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii.

Authors:  Cristina T Stoyanov; Silvia B Boscardin; Stephanie Deroubaix; Giovanna Barba-Spaeth; David Franco; Ruth S Nussenzweig; Michel Nussenzweig; Charles M Rice
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

6.  Dynamics and turnover of memory CD8 T cell responses following yellow fever vaccination.

Authors:  Veronika I Zarnitsyna; Rama S Akondy; Hasan Ahmed; Donald J McGuire; Vladimir G Zarnitsyn; Mia Moore; Philip L F Johnson; Rafi Ahmed; Kelvin W Li; Marc K Hellerstein; Rustom Antia
Journal:  PLoS Comput Biol       Date:  2021-10-14       Impact factor: 4.475

7.  Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi.

Authors:  Raquel Tayar Nogueira; Alanderson Rocha Nogueira; Mirian Claudia Souza Pereira; Maurício Martins Rodrigues; Patrícia Cristina da Costa Neves; Ricardo Galler; Myrna Cristina Bonaldo
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.